+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Direct-To-Consumer Laboratory Testing Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941105

Global Direct-to-Consumer Laboratory Testing Market Outlook

The global direct-to-consumer laboratory testing market size was valued at USD 12.4 billion in 2023, driven by increasing health awareness across the globe. The market size is anticipated to grow at a CAGR of 26.8 % during the forecast period of 2024-2032 to achieve a value of USD 105 billion by 2032.

Direct-to-Consumer Laboratory Testing: Introduction

Direct-to-consumer laboratory testing (DTC) allows individuals to order medical tests directly from a laboratory without necessarily requiring a healthcare provider's order or referral. This approach empowers consumers to manage their health proactively, offering convenience and confidentiality. Tests can range from genetic screenings to blood chemistry analyses, with results directly provided to the individual, often through online platforms. However, it's crucial for users to understand and interpret these results responsibly, potentially in consultation with healthcare professionals.

Key Trends in the Global Direct-to-Consumer Laboratory Testing Market

Consumers are becoming more proactive about their health and are seeking convenient ways to gain insights into their health status without necessarily visiting a healthcare provider.

Companies in the DTC lab testing market are continually expanding their test offerings to include a wide range of tests, from genetic screenings to tests for specific diseases or health conditions.

Advancements in technology are enabling more sophisticated at-home testing kits that can provide accurate and reliable results. This includes improvements in biosensors, data analytics, and digital health platforms.

Many DTC labs testing companies are integrating telehealth services, offering virtual consultations with healthcare professionals to discuss test results and next steps.

The DTC lab testing market is subject to regulatory scrutiny, with authorities like the FDA paying close attention to the claims made by companies and the accuracy of the tests. Regulations are evolving in response to the growth of the market.

With the increase in the collection of sensitive health data, companies are emphasizing the importance of data privacy and security, ensuring that consumer data is protected.

Companies in the DTC lab testing space are forming partnerships and collaborations with traditional healthcare providers, technology companies, and even insurance companies to expand their reach and integrate their services into the broader healthcare ecosystem.

There's a trend towards providing consumers with more educational resources to help them understand their test results and the implications for their health, promoting a more informed approach to personal health management.

Services are becoming more personalized, with companies offering customized health recommendations based on individual test results, lifestyle, and genetic information.

Global Direct-to-Consumer Laboratory Testing Market Segmentation

Market Breakup by Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

Market Breakup by Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others

Market Breakup by Distribution Channel

  • Online Platforms/Websites
  • Mobile Applications
  • Physical Retail Locations
  • Telemedicine Services
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Direct-to-Consumer Laboratory Testing Market Overview

In North America, there is a significant emphasis on personalized healthcare and wellness, driven by an increasing awareness of preventive healthcare. Consumers in this region show a strong preference for home-based testing kits for various health parameters, including genetic testing, wellness, and chronic disease monitoring. The United States market, in particular, is characterized by the presence of major market players, technological advancements, and a well-established healthcare infrastructure. Regulatory frameworks in this region, particularly in the U.S., are also adapting to accommodate and regulate the growing market of direct-to-consumer tests.

The European market for direct-to-consumer laboratory testing is marked by growing health consciousness and an increase in the aging population, which is more susceptible to chronic diseases. Countries like the UK, Germany, and France are leading in this space, driven by technological advancements and significant healthcare spending. However, the market is also navigating through stringent regulatory landscapes, especially related to data privacy (GDPR regulations) and test accuracy.

Asia Pacific is witnessing rapid growth in the direct-to-consumer laboratory testing market. This growth is fueled by increasing disposable incomes, rising awareness about preventive healthcare, and advancements in healthcare infrastructure. Countries like China, Japan, and India are pivotal markets, with a surge in demand for genetic testing and personalized health assessment services. However, the region also presents challenges, including diverse regulatory environments and cultural differences in attitudes towards health and wellness testing.

Global Direct-to-Consumer Laboratory Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • LabCorp
  • Quest Diagnostics
  • Everlywell
  • LetsGetChecked
  • HealthTap
  • AncestryDNA
  • Veritas Genetics
  • MyHeritage
  • Color Genomics
  • Helix
  • Orig3n
  • Pathway Genomics
  • Thermo Fisher Scientific
  • Genome Medical
  • HealthCheck


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Direct-to-Consumer Laboratory Testing Market Overview
3.1 Global Direct-to-Consumer Laboratory Testing Market Historical Value (2017-2023)
3.2 Global Direct-to-Consumer Laboratory Testing Market Forecast Value (2024-2032)
4 Global Direct-to-Consumer Laboratory Testing Market Landscape
4.1 Global Direct-to-Consumer Laboratory Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Direct-to-Consumer Laboratory Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Direct-to-Consumer Laboratory Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Direct-to-Consumer Laboratory Testing Market Segmentation
6.1 Global Direct-to-Consumer Laboratory Testing Market by Sample Type
6.1.1 Market Overview
6.1.2 Blood
6.1.3 Urine
6.1.4 Saliva
6.1.5 Others
6.2 Global Direct-to-Consumer Laboratory Testing Market by Test Type
6.2.1 Market Overview
6.2.2 Genetic Testing
6.2.3 Disease Risk Assessment Testing
6.2.4 CBC
6.2.5 Diabetes Testing
6.2.6 TSH Testing
6.2.7 Others
6.3 Global Direct-to-Consumer Laboratory Testing Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Online Platforms/Websites
6.3.3 Mobile Applications
6.3.4 Physical Retail Locations
6.3.5 Telemedicine Services
6.3.6 Others
6.4 Global Direct-to-Consumer Laboratory Testing Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Speciality Labs
6.4.5 Diagnostic Centres
6.4.6 Others
6.5 Global Direct-to-Consumer Laboratory Testing Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Direct-to-Consumer Laboratory Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Direct-to-Consumer Laboratory Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Direct-to-Consumer Laboratory Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Direct-to-Consumer Laboratory Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Direct-to-Consumer Laboratory Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 LabCorp
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Quest Diagnostics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Everlywell
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 LetsGetChecked
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 HealthTap
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 AncestryDNA
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Veritas Genetics
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 MyHeritage
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Color Genomics
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Helix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Orig3n
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Pathway Genomics
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Thermo Fisher Scientific
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Genome Medical
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 HealthCheck
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Direct-to-Consumer Laboratory Testing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • LabCorp
  • Quest Diagnostics
  • Everlywell
  • LetsGetChecked
  • HealthTap
  • AncestryDNA
  • Veritas Genetics
  • MyHeritage
  • Color Genomics
  • Helix
  • Orig3n
  • Pathway Genomics
  • Thermo Fisher Scientific
  • Genome Medical
  • HealthCheck

Methodology

Loading
LOADING...

Table Information